Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Bo Wylin
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
8
Results
2025
Neutrophil-derived chitinase 3-like 1 drives immunosuppression in triple-negative breast cancer : insights from a CHI3L1 knockout mouse model
Robbe Salembier
Caro De Haes
Bo Wylin
Kristel Demeyere
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2025
Structural and functional analysis of K1- and K2-specific depolymerases for targeted therapy against multidrug-resistant Klebsiella pneumoniae
Ilaria De Angelis
Inês Maria Afonso Barroso
Bo Wylin
Agnieszka Łątka
Yves Briers
C3
Conference
2025
Transcriptomic adaptation of the cold versus hot triple-negative breast tumor immune microenvironment to PD-L1 blockade
Robbe Salembier
Caro De Haes
Bo Wylin
Kristel Demeyere
Steven Van Laere
Nicolaas Van Renne
Christos Sotiriou
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2025
Transcriptomic heterogeneity of nine complementary mouse TNBC models based on their comparative in vitro and in vivo characterization
Robbe Salembier
Caro De Haes
Bo Wylin
Kristel Demeyere
Steven Van Laere
Niek Sanders
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2025
2024
Chitin-mediated blockade of chitinase-like proteins reduces tumor growth and immunosuppression in a mouse model for TNBC
Robbe Salembier
Caro De Haes
Bo Wylin
Kristel Demeyere
Niek Sanders
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2024
Comparative profiling of mouse TNBC models with differential TME states that mimic clinical heterogeneity
Robbe Salembier
Caro De Haes
Bo Wylin
Kristel Demeyere
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2024
Lipocalin-2 blockade enhances anti-PD-1 efficacy in an immunosuppressed mouse TNBC model
Caro De Haes
Robbe Salembier
Bo Wylin
Kristel Demeyere
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2024
Lipocalin-2 blockade reduces tumor growth and neutrophil infiltration in a mouse model for TNBC
Caro De Haes
Robbe Salembier
Bo Wylin
Kristel Demeyere
Niek Sanders
Evelyne Meyer
Jonas Steenbrugge
C3
Conference
2024